Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

Summary

Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks is a clinical trial^[1].

Key Facts

• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks is in the country of United States^[2].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's instance of is recorded as clinical trial^[3].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's start time is recorded as +2003-09-30T00:00:00Z^[4].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's end time is recorded as +2013-10-31T00:00:00Z^[5].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's main subject is recorded as sclerosis^[6].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's main subject is recorded as multiple sclerosis^[7].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's number of participants is recorded as {'unit': '1', 'amount': '+16'}^[8].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's title is recorded as Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)^[9].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's ClinicalTrials.gov ID is recorded as NCT00418145^[11].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[12].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research intervention is recorded as prednisolone acetate^[13].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research intervention is recorded as methylprednisolone acetate^[14].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research intervention is recorded as methylprednisolone^[15].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research intervention is recorded as methylprednisolone hemisuccinate^[16].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research intervention is recorded as prednisolone^[17].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research intervention is recorded as prednisolone hemisuccinate^[18].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research intervention is recorded as prednisolone 21-phosphate^[19].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's clinical trial phase is recorded as phase III clinical trial^[20].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research site is recorded as University of Medicine and Dentistry of New Jersey^[21].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research site is recorded as Icahn School of Medicine at Mount Sinai^[22].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research site is recorded as University of Rochester^[23].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research site is recorded as Maimonides Medical Center (Jewish)^[24].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research site is recorded as Columbia University Irving Medical Center^[25].
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks's research site is recorded as University of Vermont Children’s Hospital^[26].